Stay updated on Pembrolizumab in Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Multiple Myeloma Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Added a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.
    Difference
    3%
    Check dated 2025-10-06T16:04:42.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Adds broader topic coverage (Multiple myeloma) and updates version to v3.1.0; removes the previous MedlinePlus Genetics topic link and the term 'Plasma cell myeloma' plus older revision v3.0.2.
    Difference
    0.5%
    Check dated 2025-09-29T09:59:40.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    Added a new MedlinePlus Genetics topic: Multiple myeloma, expanding core content with genetics-related information.
    Difference
    0.2%
    Check dated 2025-09-22T05:37:13.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Version updated to v3.0.2; removed the MedlinePlus Genetics topic 'Multiple myeloma' as well as the prior v3.0.1 note and the Back to Top link.
    Difference
    0.4%
    Check dated 2025-09-15T00:28:53.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.
    Difference
    0.2%
    Check dated 2025-09-07T20:51:35.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, as well as new medical terms related to plasma cell myeloma and various chemical compounds. Notably, several previous terms related to drugs and treatments have been removed.
    Difference
    4%
    Check dated 2025-08-31T12:56:54.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Multiple Myeloma Clinical Trial page.